Prognostic Value of Whole-Body Total Lesion Glycolysis at Pretreatment FDG PET/CT in Non–Small Cell Lung Cancer

References

• 1 Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5):277–300.
  Medline Google Scholar
• 2 Richards MA, Stockton D, Babb P, Coleman MP. How many deaths have been avoided through improvements in cancer survival? BMJ 2000;320(7239):895–898.
  Medline Google Scholar
• 3 van Rens MT, de la Rivière AB, Elbers HR, van Den Bosch JM. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non–small cell lung cancer, stage I, II, and IIIA. Chest 2000;117(2):374–379.
  Medline Google Scholar
• 4 Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non–small cell lung cancer: a decade of progress. Chest 2002;122(3):1037–1057.
  Medline Google Scholar
• 5 Hicks RJ, Kalff V, MacManus MP, et al.. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non–small cell lung cancer. J Nucl Med 2001;42(11):1596–1604.
  Medline Google Scholar
• 6 Hicks RJ, Kalff V, MacManus MP, et al.. The utility of (18)F-FDG PET for suspected recurrent non–small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification. J Nucl Med 2001;42(11):1605–1613.
  Medline Google Scholar
• 7 Hoekstra CJ, Stroobants SG, Hoekstra OS, et al.. The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non–small cell lung cancer for combined modality treatment. Lung Cancer 2003;39(2):151–157.
  Medline Google Scholar
• 8 Higashi K, Ueda Y, Arisaka Y, et al.. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non–small cell lung cancer. J Nucl Med 2002;43(1):39–45.
  Medline Google Scholar
• 9 Vansteenkiste JF, Stroobants SG, Dupont PJ, et al.. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non–small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999;17(10):3201–3206.
  Medline Google Scholar
• 10 Downey RJ, Akhurst T, Gonen M, et al.. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 2004;22(16):3255–3260.
  Medline Google Scholar
• 11 Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA. The maximum standardized uptake values on positron emission tomography of a non–small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 2005;130(1):151–159.
  Medline Google Scholar
• 12 Sasaki R, Komaki R, Macapinlac H, et al.. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non–small cell lung cancer. J Clin Oncol 2005;23(6):1136–1143.
  Medline Google Scholar
• 13 Vesselle H, Freeman JD, Wiens L, et al.. Fluorodeoxyglucose uptake of primary non–small cell lung cancer at positron emission tomography: new contrary data on prognostic role. Clin Cancer Res 2007;13(11):3255–3263.
  Medline Google Scholar
• 14 Paesmans M, Berghmans T, Dusart M, et al.. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non–small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project. J Thorac Oncol 2010;5(5):612–619.
  Medline Google Scholar
• 15 Lee P, Weerasuriya DK, Lavori PW, et al.. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys 2007;69(2):328–333.
  Medline Google Scholar
• 16 Hyun SH, Choi JY, Shim YM, et al.. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol 2010;17(1):115–122.
  Medline Google Scholar
• 17 La TH, Filion EJ, Turnbull BB, et al.. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;74(5):1335–1341.
  Medline Google Scholar
• 18 Lee HY, Hyun SH, Lee KS, et al.. Volume-based parameter of (18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol 2010;17(10):2787–2794.
  Medline Google Scholar
• 19 Kim BS, Kim IJ, Kim S, et al.. The prognostic value of the metabolic tumor volume in FIGO stage IA to IIB cervical cancer for tumor recurrence: measured by F-18 FDG PET/CT. Nucl Med Mol Imaging 2011;45(1):36–42.
  Medline Google Scholar
• 20 Larson SM, Erdi Y, Akhurst T, et al.. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2(3):159–171.
  Medline Google Scholar
• 21 Roedl JB, Colen RR, Holalkere NS, Fischman AJ, Choi NC, Blake MA. Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT—comparison to histopathologic and clinical response evaluation. Radiother Oncol 2008;89(3):278–286.
  Medline Google Scholar
• 22 Erdi YE, Macapinlac H, Rosenzweig KE, et al.. Use of PET to monitor the response of lung cancer to radiation treatment. Eur J Nucl Med 2000;27(7):861–866.
  Medline Google Scholar
• 23 Veit-Haibach P, Schaefer NG, Steinert HC, Soyka JD, Seifert B, Stahel RA. Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma. Lung Cancer 2010;67(3):311–317.
  Medline Google Scholar
• 24 Guillem JG, Moore HG, Akhurst T, et al.. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg 2004;199(1):1–7.
  Medline Google Scholar
• 25 Melton GB, Lavely WC, Jacene HA, et al.. Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg 2007;11(8):961–969; discussion 969.
  Medline Google Scholar
• 26 Benz MR, Allen-Auerbach MS, Eilber FC, et al.. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. J Nucl Med 2008;49(10):1579–1584.
  Medline Google Scholar
• 27 Flamen P, Vanderlinden B, Delatte P, et al.. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Phys Med Biol 2008;53(22):6591–6603.
  Medline Google Scholar
• 28 Costelloe CM, Macapinlac HA, Madewell JE, et al.. 18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. J Nucl Med 2009;50(3):340–347.
  Medline Google Scholar
• 29 Xie P, Yue JB, Zhao HX, et al.. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2010;136(6):883–889.
  Medline Google Scholar
• 30 Greene FL, Page DL, Fleming ID, et al.. AJCC cancer staging manual. 6th ed. New York, NY: Springer-Verlag, 2002.
  Google Scholar
• 31 Duhaylongsod FG, Lowe VJ, Patz EF, Vaughn AL, Coleman RE, Wolfe WG. Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. Ann Thorac Surg 1995;60(5):1348–1352.
  Medline Google Scholar
• 32 Higashi K, Ueda Y, Yagishita M, et al.. FDG PET measurement of the proliferative potential of non–small cell lung cancer. J Nucl Med 2000;41(1):85–92.
  Medline Google Scholar
• 33 Vesselle H, Schmidt RA, Pugsley JM, et al.. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6(10):3837–3844.
  Medline Google Scholar
• 34 Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 1997;80(6):1046–1051.
  Medline Google Scholar
• 35 Sugawara Y, Quint LE, Iannettoni MD, et al.. Does the FDG uptake of primary non–small cell lung cancer predict prognosis? A work in progress. Clin Positron Imaging 1999;2(2):111–118.
  Medline Google Scholar
• 36 Bradley JD, Ieumwananonthachai N, Purdy JA, et al.. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non–small cell lung carcinoma. Int J Radiat Oncol Biol Phys 2002;52(1):49–57.
  Medline Google Scholar
• 37 Jefferson MF, Pendleton N, Faragher EB, Dixon GR, Myskow MW, Horan MA. “Tumour volume” as a predictor of survival after resection of non–small cell lung cancer (NSCLC). Br J Cancer 1996;74(3):456–459.
  Medline Google Scholar
• 38 Biehl KJ, Kong FM, Dehdashti F, et al.. 18F-FDG PET definition of gross tumor volume for radiotherapy of non–small cell lung cancer: is a single standardized uptake value threshold approach appropriate? J Nucl Med 2006;47(11):1808–1812.
  Medline Google Scholar
• 39 Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. RadioGraphics 2004;24(5):1411–1431.
  Google Scholar
• 40 Wu K, Ung YC, Hornby J, et al.. PET CT thresholds for radiotherapy target definition in non–small cell lung cancer: how close are we to the pathologic findings? Int J Radiat Oncol Biol Phys 2010;77(3):699–706.
  Medline Google Scholar
• 41 Yaremko B, Riauka T, Robinson D, Murray B, McEwan A, Roa W. Threshold modification for tumour imaging in non–small cell lung cancer using positron emission tomography. Nucl Med Commun 2005;26(5):433–440.
  Medline Google Scholar
• 42 Thorwarth D, Schaefer A. Functional target volume delineation for radiation therapy on the basis of positron emission tomography and the correlation with histopathology. Q J Nucl Med Mol Imaging 2010;54(5):490–499.
  Medline Google Scholar
• 43 Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33(11):1972–1980.
  Medline Google Scholar
• 44 Ludwig V, Komori T, Kolb D, Martin WH, Sandler MP, Delbeke D. Cerebral lesions incidentally detected on 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography images of patients evaluated for body malignancies. Mol Imaging Biol 2002;4(5):359–362.
  Medline Google Scholar